Currently, out of the existing stock ratings of Catherine Ramsey Schulte - 75 which are a Buy (89.29%), 9 which are a Hold (10.71%)

Catherine Ramsey Schulte

Work Performance Price Targets & Ratings Chart

Analyst Catherine Ramsey Schulte works at BAIRD and is covering the Healthcare sector with 168 price targets and ratings displayed on 8 stocks.

Catherine Ramsey Schulte's average stock forecast success ratio is 52.99% with an average time for price targets to be met of 65.75 days.

Most recent stock forecast was given on A, Agilent Technologies at 16-Aug-2023.

Wall Street Analyst Catherine Ramsey Schulte

Analyst best performing recommendations are on ILMN.
The best stock recommendation documented was for ILMN at 4/15/2020. The price target of $310 was fulfilled within 2 days with a profit of $15.71 (5.34%) receiving and performance score of 26.69.

Average potential price target upside

A Agilent Technologies CSTL Castle Biosciences ILMN NSTG NanoString Technologies NTRA Natera TWST TMO Thermo Fisher Scientific WAT Waters

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

150

$37.53 (33.37%)

160

1 months 5 days ago

13/19 (68.42%)

$17.89 (18.34%)

229

Buy

150

$37.53 (33.37%)

125

1 months 5 days ago

6/7 (85.71%)

$14.64 (18.27%)

266

120

$7.53 (6.70%)

124

1 months 5 days ago

6/6 (100%)

$6.72 (16.45%)

357

Buy

146

$33.53 (29.81%)

185

1 months 5 days ago

5/7 (71.43%)

$18.5 (30.18%)

530

Buy

140

$27.53 (24.48%)

144

1 months 5 days ago

8/15 (53.33%)

$17.78 (16.02%)

112

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Catherine Ramsey Schulte is most bullish on?

Potential upside of $120.11 has been obtained for TMO (THERMO FISHER SCIENTIFIC)

Which stock is Catherine Ramsey Schulte is most reserved on?

Potential downside of $27.53 has been obtained for A (AGILENT TECHNOLOGIES)

What Year was the first public recommendation made by Catherine Ramsey Schulte?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart